RxDoctor Payments Data

Katherine Stemen, APRN

Family · Powell, OHNPI 1013472059

Payments from drug & device makers

$1,322in general payments, 2019–2025

Across 83 payments — averaging $15.93 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$267
  • Novo Nordisk$145
  • AstraZeneca$131
  • Lilly USA, LLC$108
  • Pfizer$93
  • Boehringer Ingelheim$82
  • plus $496 from 13 others

What the payments were for

  • Food & beverage$1,322100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,322 in reported general payments places this provider in the 75th percentile of 6,812 family providers in Ohio.

See all family providers in Ohio

Medicare billing

Part B allowed, 2024
$20,253
Medicare patients
113
Services billed
380

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
EliquisApixaban29$15,603
MyrbetriqMirabegron28$9,010
Gabapentin38$997
Duloxetine Hcl21$902
Omeprazole38$733
Atorvastatin Calcium82$700
ValacyclovirValacyclovir Hcl14$651
Albuterol Sulfate HfaAlbuterol Sulfate22$593
Rosuvastatin Calcium90$593
Tamsulosin Hcl22$587
Escitalopram Oxalate28$450
Citalopram HbrCitalopram Hydrobromide21$416
Losartan Potassium58$399
Lisinopril57$384
Pantoprazole Sodium35$340

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
PfizerEliquis$93$15,60329 claims
Astellas Pharma US IncMyrbetriq$42$9,01028 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 75th percentile of 6,812 family providers in Ohio.

Other family in Powell

See the full list for Ohio

Where these figures come from

Is this you, or does something look wrong? →